TLX activates MMP-2, promotes self-renewal of tumor spheres in neuroblastoma and correlates with poor patient survival

Cell Death and Disease

Volumn 5, Issue 10, 2014, Pages

  Chavali, P L ^a,b   Saini, P K R ^a   Zhai, Q ^a   Vizlin Hodzic, D ^a   Venkatabalasubramanian, S ^a,c   Hayashi, A ^a   Johansson, E ^a   Zeng, Z J ^a,d   Mohlin, S ^e   Pahlman S ^e   Hansford, L ^f,g   Kaplan, D R ^f,g   Funa, K ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c SASTRA UNIVERSITY   (India)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e LUND UNIVERSITY   (Sweden)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; GELATINASE A; NUCLEAR PROTEIN; NUCLEAR PROTEIN TLX; OCTAMER TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG; CELL RECEPTOR; NR2E1 PROTEIN, HUMAN; POU5F1 PROTEIN, HUMAN; PROTEIN BINDING; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; GENE ACTIVATION; MOUSE; NEURAL STEM CELL; NEUROBLASTOMA; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; ANIMAL; CANCER STEM CELL; CELL HYPOXIA; CELL MOTION; CELL PROLIFERATION; DRUG SCREENING; ENZYME ACTIVATION; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MULTICELLULAR SPHEROID; PATHOLOGY; SCID MOUSE; SURVIVAL; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; HUMANS; MATRIX METALLOPROTEINASE 2; MICE, SCID; NEOPLASM INVASIVENESS; NEOPLASTIC STEM CELLS; NEUROBLASTOMA; OCTAMER TRANSCRIPTION FACTOR-3; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SPHEROIDS, CELLULAR; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84910122642     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.449     Document Type: Article

References (40)

1. Mahller YY, Williams JP, Baird WH, Mitton B, Grossheim J, Saeki Y et al. Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus. PLoS One 2009; 4: e4235.
2. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U et al. A distinct 'side population' of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004; 101: 14228-14233.
3. Ben-Porath I, Thomson MW, Carey VJ, Ge R, Bell GW, Regev A et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507.
4. Androutsellis-Theotokis A, Leker RR, Soldner F, Hoeppner DJ, Ravin R, Poser SW et al. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 2006; 442: 823-826.
5. Shimizu T, Kagawa T, Inoue T, Nonaka A, Takada S, Aburatani H et al. Stabilized betacatenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells. Mol Cell Biol 2008; 28: 7427-7441.
6. Goodrich LV, Milenkovic L, Higgins KM, Scott MP. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997; 277: 1109-1113.
7. Groszer M, Erickson R, Scripture-Adams DD, Lesche R, Trumpp A et al. Negative regulation of neural stem/progenitor cell proliferation by the Pten tumor suppressor gene in vivo. Science 2001; 294: 2186-2189.
8. Shi Y, Chichung Lie D, Taupin P, Nakashima K, Ray J, Yu RT et al. Expression and function of orphan nuclear receptor TLX in adult neural stem cells. Nature 2004; 427: 78-83.
9. Qu Q, Sun G, Li W, Yang S, Ye P, Zhao C et al. Orphan nuclear receptor TLX activates Wnt/ beta-catenin signalling to stimulate neural stem cell proliferation and self-renewal. Nat Cell Biol 2010; 12: 31-40.
10. Zhao C, Sun G, Li S, Shi Y. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struct Mol Biol 2009; 16: 365-371.
11. Chavali PL, Saini RK, Matsumoto Y, Agren H, Funa K. Nuclear orphan receptor TLX induces Oct-4 for the survival and maintenance of adult hippocampal progenitors upon hypoxia. J Biol Chem 2011; 286: 9393-9404.
12. Liu HK, Wang Y, Belz T, Bock D, Takacs A, Wu H et al. The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation. Genes Dev 2010; 24: 683-695.
13. Park HJ, Kim JK, Jeon HM, Oh SY, Kim SH, Jeon HM et al. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells. Mol Cell 2010; 30: 403-408.
14. Tonti GA, Mannello F, Cacci E, Biagioni S. Neural stem cells at the crossroads: MMP-s may tell the way. Int J Dev Biol 2009; 53: 1-17.
15. Gondi CS, Talluri L, Dinh DH, Gujrati M, Rao JS. RNAi-mediated downregulation of MMP-2 activates the extrinsic apoptotic pathway in human glioma xenograft cells. Int J Oncol 2009; 35: 851-859.
16. Huang AC, Hsu SC, Kuo CL, Liao CL, Lai KC, Lin TP et al. Involvement of matrix metalloproteinases in the inhibition of cell invasion and migration through the inhibition of NF-[kappa]B by the new synthesized ethyl 2-[N-p-chlorobenzyl-(2'-methyl)]anilino-4-oxo-4, 5-dihydrofuran-3-carboxylate (JOTO1007) in human cervical cancer Ca ski cells. In Vivo 2009; 23: 613-619.
17. Snuderl M, Chi SN, De Santis SM, Stemmer-Rachamimov AO, Betensky RA, De Girolami U et al. Prognostic value of tumor microinvasion and metalloproteinases expression in intracranial pediatric ependymomas. J Neuropathol Exp Neurol 2008; 67: 911-920.
18. Opel D, Poremba C, Simon T, Debatin KM, Fulda S. Activation of Akt predicts poor outcome in neuroblastoma. Cancer Res 2007; 67: 735-745.
19. Zhang CL, Zou Y, Yu RT, Gage FH, Evans RM. Nuclear receptor TLX prevents retinal dystrophy and recruits the corepressor atrophin1. Genes Dev 2006; 20: 1308-1320.
20. Hansford LM, McKee AE, Zhang L, George RE, Gerstle JT, Thorner PS et al. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell. Cancer Res 2007; 67: 11234-11243.
21. Seiki M. Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion. Cancer Lett 2003; 194: 1-11.
22. Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, Wu CL. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells. Cancer Res 2008; 68: 6281-6291.
23. Zou Y, Niu W, Qin S, Downes M, Burns DK, Zhang CL. The nuclear receptor TLX is required for gliomagenesis within the adult neurogenic niche. Mol Cell Biol 2012; 32: 4811-4820.
24. Llaguno SA, Chen J, Kwon CH, Parada LF. Neural and cancer stem cells in tumor suppressor mouse models of malignant astrocytoma. Cold Spring Harb Symp Quant Biol 2008; 73: 421-426.
25. Roy K, Kuznicki K,Wu Q, Sun Z, Bock D, Schutz G et al. The Tlx gene regulates the timing of neurogenesis in the cortex. J Neurosci 2004; 24: 8333-8345.
26. Huber K, Brühl B, Guillemot F, Olson EN, Ernsberger U, Unsicker K et al. Development of chromaffin cells depends on MASH function. Development 2002; 129: 4729-4738.
27. Pietras A, Hansford LM, Johnsson AS, Bridges E, Sjflund J, Gisselsson D et al. HIF-2a maintains an undifferentiated state in neural crest-like human neuroblastoma tumorinitiating cells. Proc Natl Acad Sci USA 2009; 106: 16805-16810.
28. Zeng Z, Johansson E, Hayashi A, Chavali P, Akrap N, Yoshida N et al. TLX controls angiogenesis through interaction with the von Hippel-Lindau protein. Biology Open 2012; 1: 527-535.
29. Yanagisawa M, Taga T, Nakamura K, Ariga T, Yu RK. Characterization of glycoconjugate antigens in mouse embryonic neural precursor cells. J Neurochem 2005; 95: 1311-1320.
30. Taylor ME, Drickamer K. Paradigms for glycan-binding receptors in cell adhesion. Curr Opin Cell Biol 2007; 19: 572-577.
31. Matsuura N, Narita T, Hiraiwa N, Hiraiwa M, Murai H, Iwase Y et al. Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewisx, the carbohydrate ligands for E-selectin, in human breast cancer. Int J Oncol 1998; 12: 1157-1164.
32. Mottet D, Dumont V, Deccache Y, Demazy C, Ninane N, Raes M et al. Regulation of hypoxiainducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J Biol Chem 2003; 278: 31277-31285.
33. Mazumdar J, O'Brien WT, Johnson RS, LaManna JC, Chavez JC, Klein N et al. O2 regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol 2010; 12: 1007-1013.
34. Favier J, Lapointe S, Maliba R, Sirois MG. HIF2 alpha reduces growth rate but promotes angiogenesis in a mouse model of neuroblastoma. BMC Cancer 2007; 26: 139-149.
35. Uemura A, Kusuhara S, Wiegand SJ, Yu RT, Nishikawa S. Tlx acts as a proangiogenic switch by regulating extracellular assembly of fibronectin matrices in retinal astrocytes. J Clin Invest 2006; 116: 369-377.
36. Saad S, Gottlieb DJ, Bradstock KF, Overall CM, Bendall LJ. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res 2002; 62: 283-289.
37. Kenny HA, Kaur S, Coussens LM, Lengyel E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest 2008; 118: 1367-1379.
38. Cannito S, Novo E, di Bonzo LV, Busletta C, Colombatto S, David E et al. Epithelialmesenchymal transition: from molecular mechanisms, redox regulation to implications in human health and disease. Antioxid Redox Signal 2010; 12: 1383-1430.
39. Kobayashi K, Takahashi H, Inoue A, Harada H, Toshimori S, Kobayashi K et al. Oct-4 promotes migration and invasion of glioblastoma cells. J Cell Biochem 2012; 113: 508-517.
40. Jornsten R, Abenius T, Kling T, Schmidt L, Johansson E, Nordling B et al. Network modeling of the transcriptional effects of copy number aberrations in glioblastoma. Mol Syst Biol 2011; 7: 486-503.